CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy and Safety of CinnaGen Recombinant Human Growth Hormone (CinnaTropin®) in Comparison With Novo Nordisk Growth Hormone (Nordilet®) Product in Pre-Pubertal Children With Idiopathic Growth Hormone Deficiency (IGHD)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03223025
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:36.757142+00:00
Published At: 2023-08-31T00:00:00+00:00
Record Updated At: 2023-08-31
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Idiopathic Growth Hormone Deficiency"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-08-31"
protocolSection.identificationModule.nctId: "NCT03223025"
protocolSection.identificationModule.officialTitle: "Efficacy and Safety of CinnaGen Recombinant Human Growth Hormone (CinnaTropin\u00ae) in Comparison With Novo Nordisk Growth Hormone (Nordilet\u00ae) Product in Pre-Pubertal Children With Idiopathic Growth Hormone Deficiency (IGHD)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.